排序方式: 共有10条查询结果,搜索用时 15 毫秒
1
1.
A new analytic relativistic model has been obtained for superdense stars by solving the Einstein field equations for the spherically symmetric and static case. The model stands all the tests of physical reality. The density,, remains positive under all conditions and decreases smoothly from the center to the surface of the structure. The pressure,P, the ratioP/ anddP/d decrease with decreasing density. For all the finite values of pressure, the configurations are stable under radial perturbation. FordP/d 1, the maximum mass of neutron star model is 4.17, and the surface and central red shifts are 0.63 and 1.60, respectively. For an infinite central pressure, the surface red shift is 1.61. The structures are bound and the binding coefficients increase with the increasing mass. 相似文献
2.
3.
Farrah Syazana Khattulanuar Mahendran Sekar Shivkanya Fuloria Siew Hua Gan Nur Najihah Izzati Mat Rani Subban Ravi Kumarappan Chidambaram M. Yasmin Begum Abul Kalam Azad Srikanth Jeyabalan Arulmozhi Dhiravidamani Lakshmi Thangavelu Pei Teng Lum Vetriselvan Subramaniyan Yuan Seng Wu Kathiresan V. Sathasivam Neeraj Kumar Fuloria 《Molecules (Basel, Switzerland)》2022,27(3)
Cardiovascular disorders (CVDs) are the leading risk factor for death worldwide, and research into the processes and treatment regimens has received a lot of attention. Tilianin is a flavonoid glycoside that can be found in a wide range of medicinal plants and is most commonly obtained from Dracocephalum moldavica. Due to its extensive range of biological actions, it has become a well-known molecule in recent years. In particular, numerous studies have shown that tilianin has cardioprotective properties against CVDs. Hence, this review summarises tilianin’s preclinical research in CVDs, as well as its mechanism of action and opportunities in future drug development. The physicochemical and drug-likeness properties, as well as the toxicity profile, were also highlighted. Tilianin can be a natural lead molecule in the therapy of CVDs such as coronary heart disease, angina pectoris, hypertension, and myocardial ischemia, according to scientific evidence. Free radical scavenging, inflammation control, mitochondrial function regulation, and related signalling pathways are all thought to play a role in tilianin’s cardioprotective actions. Finally, we discuss tilianin-derived compounds, as well as the limitations and opportunities of using tilianin as a lead molecule in drug development for CVDs. Overall, the scientific evidence presented in this review supports that tilianin and its derivatives could be used as a lead molecule in CVD drug development initiatives. 相似文献
4.
Neeraj Pant Pratibha Fuloria N. Pradhan 《International Journal of Theoretical Physics》2014,53(3):993-1002
We present a spherically symmetric solution of the general relativistic field equations in isotropic coordinates for perfect fluid, compatible with a super dense star modeling. The solution is well behaved for all the values of u lying in the range 0<u≤0.12. Further, we have constructed a super-dense star model with all degree of suitability and by assuming the surface density ρ b =2×1014 g/cm3. Corresponding to u=0.12, the resulting well behaved model has maximum mass M=0.912M Θ with radius R b ≈11.27 km and Moment of inertia 0.97×1045 gm?cm2. The good matching of our results for Vela pulsars show the stoutness of our model. 相似文献
5.
6.
Shivkanya Fuloria Muhamad Azrul Amir Yusri Mahendran Sekar Siew Hua Gan Nur Najihah Izzati Mat Rani Pei Teng Lum Subban Ravi Vetriselvan Subramaniyan Abul Kalam Azad Srikanth Jeyabalan Yuan Seng Wu Dhanalekshmi Unnikrishnan Meenakshi Kathiresan V. Sathasivam Neeraj Kumar Fuloria 《Molecules (Basel, Switzerland)》2022,27(1)
Genistein is a naturally occurring polyphenolic molecule in the isoflavones group which is well known for its neuroprotection. In this review, we summarize the efficacy of genistein in attenuating the effects of memory impairment (MI) in animals. Scopus, PubMed, and Web of Science databases were used to find the relevant articles and discuss the effects of genistein in the brain, including its pharmacokinetics, bioavailability, behavioral effects, and some of the potential mechanisms of action on memory in several animal models. The results of the preclinical studies highly suggested that genistein is highly effective in enhancing the cognitive performance of the MI animal models, specifically in the memory domain, including spatial, recognition, retention, and reference memories, through its ability to reduce oxidative stress and attenuate neuroinflammation. This review also highlighted challenges and opportunities to improve the drug delivery of genistein for treating MI. Along with that, the possible structural modifications and derivatives of genistein to improve its physicochemical and drug-likeness properties are also discussed. The outcomes of the review proved that genistein can enhance the cognitive performance and ameliorate MI in different preclinical studies, thus indicating its potential as a natural lead for the design and development of a novel neuroprotective drug. 相似文献
7.
Geethanjali Thayumanavan Srikanth Jeyabalan Shivkanya Fuloria Mahendran Sekar Monica Ravi Logesh Kumar Selvaraj Logeshwari Bala Kumarappan Chidambaram Siew Hua Gan Nur Najihah Izzati Mat Rani M. Yasmin Begum Vetriselvan Subramaniyan Kathiresan V. Sathasivam Dhanalekshmi U. Meenakshi Neeraj Kumar Fuloria 《Molecules (Basel, Switzerland)》2022,27(8)
Bisphenol A (BPA), a well-known xenoestrogen, is commonly utilised in the production of polycarbonate plastics. Based on the existing evidence, BPA is known to induce neurotoxicity and behavioural issues. Flavonoids such as silibinin and naringenin have been shown to have biological activity against a variety of illnesses. The current research evaluates the neuropharmacological effects of silibinin and naringenin in a zebrafish model against neurotoxicity and oxidative stress caused by Bisphenol A. In this study, a novel tank diving test (NTDT) and light–dark preference test (LDPT) were used in neurobehavioural investigations. The experimental protocol was planned to last 21 days. The neuroprotective effects of silibinin (10 μM) and naringenin (10 μM) in zebrafish (Danio rerio) induced by BPA (17.52 μM) were investigated. In the brine shrimp lethality assay, the 50% fatal concentrations (LC50) were 34.10 μg/mL (silibinin) and 91.33 μg/mL (naringenin) compared to the standard potassium dichromate (13.15 μg/mL). The acute toxicity investigation found no mortality or visible abnormalities in the silibinin- and naringenin-treated groups (LC50 > 100 mg/L). The altered scototaxis behaviour in LDPT caused by BPA was reversed by co-supplementation with silibinin and naringenin, as shown by decreases in the number of transitions to the light zone and the duration spent in the light zone. Our findings point to BPA’s neurotoxic potential in causing altered scototaxis and bottom-dwelling behaviour in zebrafish, as well as the usage of silibinin and naringenin as potential neuroprotectants. 相似文献
8.
Nur Hanisah Mustafa Mahendran Sekar Shivkanya Fuloria M. Yasmin Begum Siew Hua Gan Nur Najihah Izzati Mat Rani Subban Ravi Kumarappan Chidambaram Vetriselvan Subramaniyan Kathiresan V. Sathasivam Srikanth Jeyabalan Subasini Uthirapathy Sivasankaran Ponnusankar Pei Teng Lum Vijay Bhalla Neeraj Kumar Fuloria 《Molecules (Basel, Switzerland)》2022,27(6)
Sarsasapogenin is a natural steroidal sapogenin molecule obtained mainly from Anemarrhena asphodeloides Bunge. Among the various phytosteroids present, sarsasapogenin has emerged as a promising molecule due to the fact of its diverse pharmacological activities. In this review, the chemistry, biosynthesis and pharmacological potentials of sarsasapogenin are summarised. Between 1996 and the present, the relevant literature regarding sarsasapogenin was obtained from scientific databases including PubMed, ScienceDirect, Scopus, and Google Scholar. Overall, sarsasapogenin is a potent molecule with anti-inflammatory, anticancer, antidiabetic, anti-osteoclastogenic and neuroprotective activities. It is also a potential molecule in the treatment for precocious puberty. This review also discusses the metabolism, pharmacokinetics and possible structural modifications as well as obstacles and opportunities for sarsasapogenin to become a drug molecule in the near future. More comprehensive preclinical studies, clinical trials, drug delivery, formulations of effective doses in pharmacokinetics studies, evaluation of adverse effects and potential synergistic effects with other drugs need to be thoroughly investigated to make sarsasapogenin a potential molecule for future drug development. 相似文献
9.
Shinde Shivkanya Bhushan Prabhakar Ghosh Swatilekha 《Journal of Solid State Electrochemistry》2022,26(12):2817-2828
Journal of Solid State Electrochemistry - Nickel–Tin (Ni–Sn) film was fabricated by aluminum (Al) induced electroless process on copper foils as a current collector. This film was... 相似文献
10.
Charles Gnanaraj Mahendran Sekar Shivkanya Fuloria Shasank S. Swain Siew Hua Gan Kumarappan Chidambaram Nur Najihah Izzati Mat Rani Tavamani Balan Sarah Stephenie Pei Teng Lum Srikanth Jeyabalan M. Yasmin Begum Vivek Chandramohan Lakshmi Thangavelu Vetriselvan Subramaniyan Neeraj Kumar Fuloria 《Molecules (Basel, Switzerland)》2022,27(9)
Parkinson’s disease (PD) and Alzheimer’s disease (AD) are neurodegenerative disorders that have emerged as among the serious health problems of the 21st century. The medications currently available to treat AD and PD have limited efficacy and are associated with side effects. Natural products are one of the most vital and conservative sources of medicines for treating neurological problems. Karanjin is a furanoflavonoid, isolated mainly from Pongamia pinnata with several medicinal plants, and has been reported for numerous health benefits. However, the effect of karanjin on AD and PD has not yet been systematically investigated. To evaluate the neuroprotective effect of karanjin, extensive in silico studies starting with molecular docking against five putative targets for AD and four targets for PD were conducted. The findings were compared with three standard drugs using Auto Dock 4.1 and Molegro Virtual Docker software. Additionally, the physiochemical properties (Lipinski rule of five), drug-likeness and parameters including absorption, distribution, metabolism, elimination and toxicity (ADMET) profiles of karanjin were also studied. The molecular dynamics (MD) simulations were performed with two selective karanjin docking complexes to analyze the dynamic behaviors and binding free energy at 100 ns time scale. In addition, frontier molecular orbitals (FMOs) and density-functional theory (DFT) were also investigated from computational quantum mechanism perspectives using the Avogadro-ORCA 1.2.0 platform. Karanjin complies with all five of Lipinski’s drug-likeness rules with suitable ADMET profiles for therapeutic use. The docking scores (kcal/mol) showed comparatively higher potency against AD and PD associated targets than currently used standard drugs. Overall, the potential binding affinity from molecular docking, static thermodynamics feature from MD-simulation and other multiparametric drug-ability profiles suggest that karanjin could be considered as a suitable therapeutic lead for AD and PD treatment. Furthermore, the present results were strongly correlated with the earlier study on karanjin in an Alzheimer’s animal model. However, necessary in vivo studies, clinical trials, bioavailability, permeability and safe dose administration, etc. must be required to use karanjin as a potential drug against AD and PD treatment, where the in silico results are more helpful to accelerate the drug development. 相似文献
1